Belimumab Clinical Trials
10 recruitingDrug
Phase 24Phase 33Phase 42Phase 12
Showing 1–10 of 10 trials
Recruiting
Phase 1
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
Systemic Lupus Erythematosus
GlaxoSmithKline142 enrolled27 locationsNCT06576271
Recruiting
Phase 1
Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID)20 enrolled1 locationNCT04097561
Recruiting
Phase 2
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Systemic Sclerosis
Hospital for Special Surgery, New York30 enrolled1 locationNCT03844061
Recruiting
Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Lung Diseases, Interstitial
GlaxoSmithKline440 enrolled131 locationsNCT06572384
Recruiting
Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
Membranous NephropathyNephrotic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID)58 enrolled20 locationsNCT03949855
Recruiting
Phase 2Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Scleroderma, SystemicSystemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline300 enrolled131 locationsNCT05878717
Recruiting
Phase 3
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Connective Tissue Diseases
GlaxoSmithKline514 enrolled10 locationsNCT06716606
Recruiting
Phase 2
Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)
VasculitisCryoglobulinemia
Assistance Publique - Hôpitaux de Paris48 enrolled20 locationsNCT04629144
Recruiting
Phase 4
Belimumab After Rituximab in Resistant Primary Juvenile SS
Pediatric ALLSjogren's Syndrome
Peking Union Medical College Hospital15 enrolled1 locationNCT06410833
Recruiting
Phase 4
Trial of Belimumab in Early Lupus
Lupus ErythematosusLupus Erythematosus, Systemic
Northwell Health30 enrolled1 locationNCT03543839